Management of Extensive Abdominal Aortic Calcifications in Older Adults

Risk Stratification and Prognostic Implications

Aggressive cardiovascular risk factor modification is the cornerstone of management for extensive abdominal aortic calcifications, as these calcified lesions serve as powerful markers of systemic atherosclerosis and independently predict cardiovascular mortality, even though they are more stable than non-calcified plaques 1
Calcified plaques are relatively stable with lower embolic risk compared to non-calcified plaques, but this does not eliminate cardiovascular risk 1

The American College of Cardiology recommends targeting LDL-C <55 mg/dL (<1.4 mmol/L) with high-intensity statin therapy to prevent progression of atherosclerotic disease 1
Use single antiplatelet therapy (aspirin or clopidogrel) only if there is documented prior embolic events or concomitant coronary disease 1
Do NOT use dual antiplatelet therapy or anticoagulation for aortic plaques alone—these provide no benefit and significantly increase bleeding risk 1
Target <140/90 mmHg for chronic management 1
Consider beta-blockers to reduce aortic wall stress, particularly given the calcified nature of the vessel 1

Duplex ultrasound every 3 years is appropriate for calcified changes without aneurysmal dilation 1
If aortic diameter is 25-30 mm, increase surveillance to every 4 years in patients with life expectancy >2 years 1
Use cardiovascular CT or MRI if duplex ultrasound does not allow adequate measurement 1
Annual visits to assess cardiovascular risk factors and treatment compliance 1
Monitor for symptom development suggesting progression or complications 1

The European Heart Journal notes that the calcified aorta presents major technical challenges for surgical or interventional procedures 2, 3
MSCT is essential for preprocedural planning when cardiac interventions are considered, as it evaluates calcium distribution, aortic root anatomy, and peripheral artery pathology 4, 5
Calcification assessment aids in risk stratification before transcatheter aortic valve replacement (TAVI) or other interventions 4
Extensive calcification may preclude certain access routes for endovascular procedures, requiring alternative approaches 6
Asymptomatic calcified stenosis does not benefit from intervention and may increase procedural risks 1

Do not assume calcification eliminates all risk—calcified lesions still indicate systemic atherosclerotic burden requiring aggressive risk factor modification 1
Avoid fluoroquinolones unless absolutely necessary with no alternative, as they increase risk of aortic complications 1
Assess the entire aorta, not just the abdominal segment, given high prevalence of multi-site disease 1
Do not rely on chest X-ray alone in high-risk patients—proceed directly to definitive imaging (CT or MRI) when aortic complications are suspected 1